Cargando…
Focal segmental glomerulosclerosis associated with the use of the IL-23 inhibitor guselkumab
We report a case of a 38-year-old man who developed a nephrotic syndrome shortly after the start of guselkumab for the treatment of plaque psoriasis. Renal biopsy showed focal segmental glomerulosclerosis (FSGS). The clinical course of our case is highly suspect for drug-induced FSGS since the nephr...
Autores principales: | Stryckers, Marijke, Van Oevelen, Stefaan, Koshy, Priyanka, Sprangers, Ben, Van Craenenbroeck, Amaryllis H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539213/ https://www.ncbi.nlm.nih.gov/pubmed/37779841 http://dx.doi.org/10.1093/ckj/sfad161 |
Ejemplares similares
-
Deconvolution of Focal Segmental Glomerulosclerosis Pathophysiology Using Transcriptomics Techniques
por: Deleersnijder, Dries, et al.
Publicado: (2021) -
Successful long-term management of recurrent focal segmental glomerulosclerosis after kidney transplantation with costimulation blockade
por: Mühlbacher, Thomas, et al.
Publicado: (2020) -
Calciprotein particles and fibroblast growth factor 23 contribute to the pathophysiology of hypercalcemia in a patient with renal sarcoidosis
por: Iwazu, Yoshitaka, et al.
Publicado: (2019) -
Genetics of focal segmental glomerulosclerosis
por: Woroniecki, Robert P., et al.
Publicado: (2007) -
Pathophysiology of focal segmental glomerulosclerosis
por: Reidy, Kimberly, et al.
Publicado: (2007)